Introgen`s INGN 241 Product Potentially Useful Gene Therapy for Human Melanoma
(PR Newswire)...INGN 241 is currently in Phase I clinical development for the treatment of solid tumors.......Introgen is also conducting a Phase II clinical trial for INGN 201 in lung cancer and Phase I trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder, brain, and breast cancer....- Mar 02 9:00 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010302/daf001_2.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines